Abstract
C(3)H/He mice were exposed to total-body X-irradiation of 1000 roentgens and received thereafter 10(7) xenogeneic Wistar rat marrow cells intravenously. In these rat-to-mouse chimeras, serum interferon-producing capacity upon injection of Newcastle disease virus was examined four weeks after grafting. Normal levels of circulating interferon were produced. The interferon, however, had the species specificity of rat interferon, being 20 times more active in rat embryo fibroblasts than in mouse embryo fibroblasts. Moreover, it behaved like rat interferon when filtered on Sephadex G-100 dextran gel, displaying one peak of activity in the 90,000 molecular-weight range and two incompletely separated peaks of 32,000 and 24,000, respectively, in the 30,000 molecular-weight region. The fact that the interferon is of the donor type in rat-to-mouse chimeras permits us to conclude that circulating interferon induced by New-castle disease virus is made in bone-marrow-derived cells.
References
May 1, 1968·The Journal of General Virology·E De Maeyer, J De Maeyer-Guignard
Apr 1, 1968·Virology·J V HallumT C Merigan
Feb 28, 1966·Biochimica Et Biophysica Acta·E Schonne
Apr 1, 1967·The Journal of Experimental Medicine·T J Smith, R R Wagner
Sep 12, 1957·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·A ISAACS, J LINDENMANN
Feb 1, 1959·Proceedings of the Society for Experimental Biology and Medicine·I C SHEKARCHI, T MAKINODAN
Aug 21, 1959·Science·H EAGLE
Apr 1, 1963·Transplantation·H BALNER
Sep 13, 1963·Science·S BARON, C E BUCKLER
Mar 1, 1964·Journal of General Microbiology·G E GIFFORDE HELLER
Aug 21, 1964·Science·T C MERIGAN
Aug 21, 1964·Science·S BARONC E BUCKLER
Sep 1, 1964·Virology·E DEMAEYER, E SCHONNE
Citations
Jan 1, 1980·Archives of Virology·A PuglieseG Forni
Mar 4, 1999·Journal of the Neurological Sciences·L DurelliG Aimo
Sep 6, 2000·Veterinary Immunology and Immunopathology·J Harris, D J Bird
Jun 8, 2002·Veterinary Immunology and Immunopathology·Elin JohanssonC Fossum
Mar 1, 1997·The International Journal of Biochemistry & Cell Biology·W S YeowC M Lai
Dec 11, 2002·The European Journal of Neuroscience·Karl Georg HäuslerUwe-Karsten Hanisch
Jul 6, 1972·The New England Journal of Medicine·S E Grossberg
Jul 1, 1997·Journal of Neuroimmunology·K G BeckerW E Biddison
Aug 17, 2000·The Journal of Infectious Diseases·S N Han, S N Meydani
Jan 1, 1981·Immunogenetics·O AscherD H Pluznik
Jan 1, 1980·Annals of the New York Academy of Sciences·E De Maeyer, J De Maeyer-Guignard
Jul 26, 2005·Autoimmunity·J D Miller, L H Whitehair
Aug 27, 1998·Journal of Dental Research·T SakutaH Takada
Oct 3, 1999·Gene Therapy·G J Prud'homme, Y Chang
Jan 27, 1971·Nature: New Biology·E De MaeyerI Montagnier
Feb 17, 1971·Nature: New Biology·J de Maeyer-Guignard, E de Maeyer
Dec 9, 1998·Clinical and Experimental Immunology·P A KnolleA W Lohse
Oct 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Blaire L OsbornCynthia Sung
Apr 30, 2003·Journal of Virology·Karen HackneyPaul Britton
May 19, 2010·Laboratory Investigation; a Journal of Technical Methods and Pathology·Correne A DeCarloIngeborg Zehbe
Nov 1, 1974·Infection and Immunity·P JullienE De Maeyer